Related Experiment Videos
Compound heterozygotes in hyperphenylalaninaemia
Insights
Most patients with moderately high phenylalanine levels are compound heterozygotes for hyperphenylalaninaemia and phenylketonuria. Genetic testing can clarify these complex genotypes in affected families.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Hyperphenylalaninaemia is a metabolic disorder characterized by elevated phenylalanine levels.
- Phenylketonuria is a severe form of hyperphenylalaninaemia requiring dietary management.
- Understanding the genetic basis of these conditions is crucial for diagnosis and treatment.
Observation:
- The study presents three children diagnosed with hyperphenylalaninaemia and their affected mothers.
- Genetic analysis revealed at least one child as a compound heterozygote for hyperphenylalaninaemia and phenylketonuria.
- Family members underwent L-phenylalanine loading tests and phenylalanine hydroxylase determination.
Findings:
- Most patients exhibiting moderately elevated serum phenylalanine levels possess a hyperphenylalaninaemia/phenylketonuria genotype.
- These individuals are typically compound heterozygotes, inheriting different mutations from each parent.
- Diagnostic tests like phenylalanine loading and enzyme assays are key to identifying these genotypes.
Implications:
- Accurate genetic diagnosis is essential for managing patients with hyperphenylalaninaemia and phenylketonuria.
- Identifying compound heterozygotes allows for tailored genetic counseling and potential therapeutic strategies.
- This research refines our understanding of the genetic spectrum of hyperphenylalaninaemia, impacting clinical practice.
Abstract:
Three children with hyperphenylalaninaemia and hyperphenylalaninaemic mothers are presented. At least one of the affected children was a compound heterozygote for hyperphenylalaninaemia and phenylketonuria. The families were examined by an L-phenylalanine loading test, by direct determination of phenylalanine hydroxylase and/or a loading test with hepta-deuterophenylalanine. We conclude that most of the patients with moderately elevated serum phenylalanine should have the genotype hyperphenylalaninaemia/phenylketonuria, i.e. they are compound heterozygotes.